Featuring a slide presentation and related discussion from Dr Jonathan Strosberg, including the following topics:

Overview of the classification, grading and incidence of neuroendocrine carcinoma (NEC) (0:00)
Overview of mutational profile, biomarker assessments and prognosis of NEC (3:45)
Current treatment paradigm for extrapulmonary NEC (8:59)
DLL3 as an emerging target biomarker in extrapulmonary NEC (17:46)
Novel therapeutic agents under investigation for extrapulmonary NEC (23:05)

China & Chagos